Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014755
Filing Date
2024-11-07
Accepted
2024-11-07 07:35:47
Documents
108
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20240930x10q.htm   iXBRL 10-Q 2974805
2 EX-31.1 xoma-20240930xex31d1.htm EX-31.1 10597
3 EX-31.2 xoma-20240930xex31d2.htm EX-31.2 10626
4 EX-32.1 xoma-20240930xex32d1.htm EX-32.1 8671
  Complete submission text file 0001558370-24-014755.txt   14214549

Data Files

Seq Description Document Type Size
5 EX-101.SCH xoma-20240930.xsd EX-101.SCH 116959
6 EX-101.CAL xoma-20240930_cal.xml EX-101.CAL 76755
7 EX-101.DEF xoma-20240930_def.xml EX-101.DEF 575719
8 EX-101.LAB xoma-20240930_lab.xml EX-101.LAB 842359
9 EX-101.PRE xoma-20240930_pre.xml EX-101.PRE 796514
111 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20240930x10q_htm.xml XML 2580216
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 241433210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)